EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Challenges and opportunities in hydroxyurea access and adherence for sickle cell disease patients at Komfo Anokye Teaching Hospital: Insights from healthcare providers

Josephine Mensah iD, Afia Frimpomaa Asare Marfo, Mercy Naa Aduele Opare-Addo, Paul Obeng, Amos Amoako-Adusei, Karl Osei Afoduo, Bright Ansah Adjei iD, Pauline Boachie Ansah iD, Kwame Ohene Buabeng

PLOS One · 29.05.2026 · 21 (5) · e0347848

DOI: 10.1371/journal.pone.0347848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 29.05.2026. Verfasst von Josephine Mensah und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Directorate, University of Ghana Medical Centre Ltd, Legon, Accra, Ghana. Hauptthemen laut MEDLINE: Hydroxyurea, Anemia, Sickle Cell, Health Personnel, Antisickling Agents. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hydroxyurea is a vital medication for managing Sickle cell disease, yet access and adherence remain significant challenges in low-resource settings. This qualitative study explored challenges and opportunities in hydroxyurea access and adherence among Sickle cell disease patients at the Komfo Anokye Teaching Hospital in Ghana. Alongside, the utility of the Ahodwo CommCare mobile App in enhancing Sickle cell disease management was explored. Semi-structured interviews were conducted with six healthcare providers, including doctors, nurses, and pharmacists from May 12 to August 15, 2022. This study found that the key barriers to hydroxyurea access and adherence include financial constraints, medication stock-outs, administrative inefficiencies, bureaucratic delays, patient-related factors such as forgetfulness and concerns about side effects, and practical challenges in administering the medication especially to children. The healthcare workers indicated that reconstituting the medication into suspension added both cost and time constraints to children who cannot take capsules hence affecting access to hydroxyurea. Facilitators to access and adherence identified included patient education, streamlined procurement processes, and government support for medication subsidies. This study found that patient education sessions should emphasize the benefits of hydroxyurea treatment and the importance of adherence to prescribed regimens. The study also revealed limited awareness and utilization of the Ahodwo CommCare app among healthcare personnel, highlighting the need for targeted training and integration into clinical workflows. These findings underscore the importance of multifaceted interventions involving healthcare workers, hospital management, and government stakeholders to improve hydroxyurea access and adherence, ultimately enhancing Sickle cell disease patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydroxyureaAnemia, Sickle CellHealth PersonnelAntisickling AgentsMedication AdherenceHumansHospitals, TeachingGhanaFemaleMaleHealth Services AccessibilityAdultChild

Substanzen

HydroxyureaAntisickling Agents

Autor:innen und Institutionen

  • Pharmacy Directorate, University of Ghana Medical Centre Ltd, Legon, Accra, Ghana.
  • Department of Pharmacy Practice, FPPS, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Department of Pharmacy, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
  • Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana.
  • Medical and Scientific Research Centre, University of Ghana Medical Centre Ltd, Legon, Accra, Ghana.

ORCID-Profile: Josephine Mensah, Bright Ansah Adjei, Pauline Boachie Ansah

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Mensah, J., Marfo, A. F. A., Opare-Addo, M. N. A., Obeng, P., Amoako-Adusei, A., Afoduo, K. O., Adjei, B. A., Ansah, P. B., & Buabeng, K. O. (2026). Challenges and opportunities in hydroxyurea access and adherence for sickle cell disease patients at Komfo Anokye Teaching Hospital: Insights from healthcare providers. PLOS One, 21(5), e0347848. https://doi.org/10.1371/journal.pone.0347848

Vancouver

Mensah J, Marfo AFA, Opare-Addo MNA, Obeng P, Amoako-Adusei A, Afoduo KO, et al. Challenges and opportunities in hydroxyurea access and adherence for sickle cell disease patients at Komfo Anokye Teaching Hospital: Insights from healthcare providers. PLOS One. 2026;21(5):e0347848. doi:10.1371/journal.pone.0347848

BibTeX
@article{Mensah2026,
  author = {Mensah, Josephine and Marfo, Afia Frimpomaa Asare and Opare-Addo, Mercy Naa Aduele and Obeng, Paul and Amoako-Adusei, Amos and Afoduo, Karl Osei and Adjei, Bright Ansah and Ansah, Pauline Boachie and Buabeng, Kwame Ohene},
  title = {Challenges and opportunities in hydroxyurea access and adherence for sickle cell disease patients at Komfo Anokye Teaching Hospital: Insights from healthcare providers},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {5},
  pages = {e0347848},
  doi = {10.1371/journal.pone.0347848}
}
Kostenlos starten →